Sotac Pharmaceuticals Limited (NSE: SOTAC)
India
· Delayed Price · Currency is INR 109.50
-5.40 (-4.70%)
At close: Dec 20, 2024
Sotac Pharmaceuticals Revenue
Sotac Pharmaceuticals had revenue of 273.46M INR in the quarter ending September 30, 2024, with 2.52% growth. This brings the company's revenue in the last twelve months to 1.05B, up 17.35% year-over-year. In the fiscal year ending March 31, 2024, Sotac Pharmaceuticals had annual revenue of 1.04B with 34.13% growth.
Revenue (ttm)
1.05B
Revenue Growth
+17.35%
P/S Ratio
1.15
Revenue / Employee
15.42M
Employees
68
Market Cap
1.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 1.04B | 264.48M | 34.13% |
| Mar 31, 2023 | 774.83M | 43.32M | 5.92% |
| Mar 31, 2022 | 731.52M | 243.09M | 49.77% |
| Mar 31, 2021 | 488.43M | 202.40M | 70.76% |
| Mar 31, 2020 | 286.04M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries Limited | 9,249.38B |
| Tata Consultancy Services Limited | 2,486.92B |
| HDFC Bank Limited | 2,761.06B |
| Bharti Airtel Limited | 1,554.78B |
| ICICI Bank Limited | 1,638.51B |
| Infosys Limited | 1,578.13B |
| State Bank of India | 3,360.28B |
| ITC Limited | 751.35B |